Desferrioxamine, an iron chelator, enhances HIF-1alpha accumulation via cyclooxygenase-2 signaling pathway - PubMed (original) (raw)
. 2006 Apr 28;343(1):8-14.
doi: 10.1016/j.bbrc.2006.02.116. Epub 2006 Feb 28.
Affiliations
- PMID: 16527254
- DOI: 10.1016/j.bbrc.2006.02.116
Desferrioxamine, an iron chelator, enhances HIF-1alpha accumulation via cyclooxygenase-2 signaling pathway
Kyung Jin Woo et al. Biochem Biophys Res Commun. 2006.
Abstract
Cyclooxygenase-2 (COX-2) is an important inducible enzyme in inflammation and is overexpressed in a variety of cancers. Evidence is rapidly accumulating that chronic inflammation may contribute to carcinogenesis through increase of cell proliferation, angiogenesis, and metastasis in a number of neoplasms, including colorectal carcinoma. In the present study, we investigated some mechanistic aspects of DFX-induced hypoxia-driven COX-2 expression. Desferrioxamine (DFX), an iron chelator, is known to upregulate inflammatory mediators. DFX induced the expression of COX-2 and accumulation of HIF-1alpha protein in dose-dependent manners, but hypoxia mimetic agent cobalt chloride (CoCl2) induced accumulation of HIF-1alpha protein but not increase of COX-2 expression. DFX-induced increase of COX-2 expression and HIF-1alpha protein level was attenuated by addition of ferric citrate. This result suggested that the iron chelating function of DFX was important to induce the increase of COX-2 and HIF-1alpha protein. PD98059 significantly inhibited the induction of COX-2 protein and accumulation of HIF-1alpha, suggesting that DFX-induced increase of HIF-1alpha and COX-2 protein was mediated, at least in part, through the ERK signaling pathway. In addition, pretreatment with NS-398 to inhibit COX-2 activity also effectively suppressed DFX-induced HIF-1alpha accumulation in human colon cancer cells, providing the evidence that COX-2 plays as a regulator of HIF-1alpha accumulation in DFX-treated colon cancer cells. Together, our findings suggest that iron metabolism may regulate stabilization of HIF-1alpha protein by modulating cyclooxygenase-2 signaling pathway.
Similar articles
- Transplantation of human neural stem cells protect against ischemia in a preventive mode via hypoxia-inducible factor-1alpha stabilization in the host brain.
Chu K, Jung KH, Kim SJ, Lee ST, Kim J, Park HK, Song EC, Kim SU, Kim M, Lee SK, Roh JK. Chu K, et al. Brain Res. 2008 May 1;1207:182-92. doi: 10.1016/j.brainres.2008.02.043. Epub 2008 Mar 4. Brain Res. 2008. PMID: 18371939 - Nitric oxide reverses desferrioxamine- and hypoxia-evoked HIF-1alpha accumulation--implications for prolyl hydroxylase activity and iron.
Callapina M, Zhou J, Schnitzer S, Metzen E, Lohr C, Deitmer JW, Brüne B. Callapina M, et al. Exp Cell Res. 2005 May 15;306(1):274-84. doi: 10.1016/j.yexcr.2005.02.018. Epub 2005 Mar 20. Exp Cell Res. 2005. PMID: 15878351 - Expression of proinflammatory cytokines via HIF-1alpha and NF-kappaB activation on desferrioxamine-stimulated HMC-1 cells.
Jeong HJ, Chung HS, Lee BR, Kim SJ, Yoo SJ, Hong SH, Kim HM. Jeong HJ, et al. Biochem Biophys Res Commun. 2003 Jul 11;306(4):805-11. doi: 10.1016/s0006-291x(03)01073-8. Biochem Biophys Res Commun. 2003. PMID: 12821113 - Natural Flavonoids as Anticancer Agents: Targeting the HIF-1α Signaling Pathway.
Shinde N, Satalkar A, Bhosale S, Patole V, Agale S. Shinde N, et al. Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2025 Jun 9;41:e20250008. doi: 10.62958/j.cjap.2025.008. Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2025. PMID: 40484654 Review. - Advances in Hypoxia-Inducible Factor-1_α_ Stabilizer Deferoxamine in Tissue Engineering.
Zhu Y, Chang B, Pang Y, Wang H, Zhou Y. Zhu Y, et al. Tissue Eng Part B Rev. 2023 Aug;29(4):347-357. doi: 10.1089/ten.TEB.2022.0168. Epub 2023 Feb 1. Tissue Eng Part B Rev. 2023. PMID: 36475887 Review.
Cited by
- Iron deficiency exacerbates cisplatin- or rhabdomyolysis-induced acute kidney injury through promoting iron-catalyzed oxidative damage.
Zhao S, Wang X, Zheng X, Liang X, Wang Z, Zhang J, Zhao X, Zhuang S, Pan Q, Sun F, Shang W, Barasch J, Qiu A. Zhao S, et al. Free Radic Biol Med. 2021 Sep;173:81-96. doi: 10.1016/j.freeradbiomed.2021.07.025. Epub 2021 Jul 21. Free Radic Biol Med. 2021. PMID: 34298093 Free PMC article. - Endothelial differentiation of bone marrow mesenchyme stem cells applicable to hypoxia and increased migration through Akt and NFκB signals.
Liu C, Tsai AL, Li PC, Huang CW, Wu CC. Liu C, et al. Stem Cell Res Ther. 2017 Feb 7;8(1):29. doi: 10.1186/s13287-017-0470-0. Stem Cell Res Ther. 2017. PMID: 28173835 Free PMC article. - Hypoxia enhances osteogenic differentiation in retinoic acid-treated murine-induced pluripotent stem cells.
Manokawinchoke J, Osathanon T, Egusa H, Pavasant P. Manokawinchoke J, et al. Tissue Eng Regen Med. 2016 Oct 20;13(5):547-553. doi: 10.1007/s13770-016-9127-9. eCollection 2016 Oct. Tissue Eng Regen Med. 2016. PMID: 30603435 Free PMC article. - Iron chelation and 2-oxoglutarate-dependent dioxygenase inhibition suppress mantle cell lymphoma's cyclin D1.
Babosova O, Kapralova K, Raskova Kafkova L, Korinek V, Divoky V, Prchal JT, Lanikova L. Babosova O, et al. J Cell Mol Med. 2019 Nov;23(11):7785-7795. doi: 10.1111/jcmm.14655. Epub 2019 Sep 13. J Cell Mol Med. 2019. PMID: 31517438 Free PMC article. - Neuropilin-1 Controls Endothelial Homeostasis by Regulating Mitochondrial Function and Iron-Dependent Oxidative Stress.
Issitt T, Bosseboeuf E, De Winter N, Dufton N, Gestri G, Senatore V, Chikh A, Randi AM, Raimondi C. Issitt T, et al. iScience. 2019 Jan 25;11:205-223. doi: 10.1016/j.isci.2018.12.005. Epub 2018 Dec 11. iScience. 2019. PMID: 30623799 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous